CCHT is a RTO that creates and develops products and technologies mostly for molecular medicine. More specifically, our research projects aim to identify disease biomarkers and develop novel technologies for reproductive medicine.
CCHT is one of the few private limited companies in Estonia that has been positively evaluated by the Estonian Ministry of Education and Research for its research & development activities.
Areas of activity:
Company’s research projects aim at providing novel solutions for female reproductive medicine.
GlobinLock, Fertify, TAC-seq technology.
Leading Estonian and European scientists, universities and biotechnology companies.